News Ticker

[ October 9, 2026 ] Diabetes Sales Associate Los Angeles Biotech Jobs
[ October 9, 2026 ] Strongpoint Partners Platform Grows with Addition of Hilde Minkel & Associates Los Angeles Biotech News
[ October 9, 2026 ] HICE and Gabeo.ai Join Forces to Advance Transparency in Healthcare Risk Contracts Los Angeles Biotech News
[ October 8, 2026 ] SELENA GOMEZ ANNOUNCES LEON BRIDGES AND BELLA KAY AS ENTERTAINMENT FOR THE FOURTH ANNUAL RARE IMPACT FUND BENEFIT Los Angeles Biotech News
[ October 8, 2026 ] Lear Capital’s New “Outside the Dollar” Podcast Reaches Top 15 on Apple Investing Chart Los Angeles Biotech News

Merck puts KRAS cancer drug competitor to the test

April 4, 2024 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off

Merck & Co. has begun a large clinical trial testing an experimental cancer drug it’s developing for tumors that harbor mutations in a tough-to-target gene called KRAS,
The Phase 3 study, which is set to enroll some 600 people with a common form of metastatic lung cancer, will…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Copyright © 2026 Biotech Networks, LLC